View Clinical Trial (Medical Research Study)
Portable Monitoring for Diagnosis and Management of Sleep Apnea - NCT00642486-44106(Clinical Trial 210967)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Cleveland |
|
State:
|
|
OH |
| Zip Code: |
|
44106 |
| Conditions: |
|
Sleep Apnea, Obstructive |
| Purpose: |
|
This multi-site project compares compares the efficiency of a home-based portable monitoring
strategy to a standard of care sleep laboratory-based strategy for the diagnosis and
positive airway pressure treatment of obstructive sleep apnea in adults.
|
| Study summary: |
|
The study is a randomized, parallel group, unblinded, multicenter study that compares two
approaches [home-based, portable monitoring (PM) versus attended, laboratory-based
polysomnography (PSG) (Lab)] in adults, at least 18 years of age, with a moderate to high
probability of obstructive sleep apnea (OSA) and who have been referred to sleep medicine
specialists at AASM-accredited sleep centers for evaluation and/or management. The study is
designed to compare the utility of the two approaches (PM group vs. Lab group) for the
diagnosis and management of OSA in adults. Approximately 372 eligible adults will be
randomized at screening to either the PM or Lab arm (186 per arm), undergo baseline OSA
testing to confirm diagnosis and study eligibility, then receive positive airway pressure
(PAP) titration studies to determine the level of pressure needed to treat their OSA. For
qualifying participants, the titration study will be lab-based in the Lab group and be
home-based using a commercially available portable, automatic PAP device (APAP) in the PM
group. All qualifying study participants will have access to study CPAP equipment and
supplies to treat their OSA. Primary outcomes (time from diagnosis to effective treatment,
patient outcomes, and relative resource utilization) are determined at 1 and 3 months after
starting CPAP treatment. Study participants who complete all of their study visits will
keep their CPAP machine at the end of the study. |
| Criteria: |
|
Inclusion Criteria:
- Intermediate to high probability of having OSA based on an adjusted neck
circumference > 43 cm (17 inches)
- Presence of excessive daytime sleepiness (Epworth sleepiness scale ≥ 12)
Exclusion Criteria:
- Severe chronic insomnia, other condition with < 4 hrs of sleep per night
- Unstable medical conditions
- Major psychiatric diagnosis
- Unable to undergo home testing
- Concerns about unsafe driving
- Severe COPD or restrictive lung disease
- Chronic narcotic use
- Alcohol abuse
- History of cataplexy
- Moderate to severe restless legs syndrome symptoms
- Pre-existing diagnosis of sleep apnea
- Prior experience with positive airway pressure treatment of sleep apnea
- Anticipated upper airway surgery or gastric bypass surgery in 4 months
- Decisional impairment for consenting
- Hypoventilation syndrome, identified in the medical record
- Waking oxygen saturation < 92% |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 21, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|